At the start of 2016, Johnson & Johnson (J&J) undertook a massive restructuring aimed at turning around its medical device business. The New Brunswick, N.J., conglomerate has been gradually swapping in high-growth device businesses and ushering out low-growth ones, a disciplined, rational effort that seems to be starting to pay off. Read More
